Patients with lupus nephritis who receive higher initial doses of glucocorticoids demonstrate improved renal outcomes, albeit with increased serious infection and mortality risks, according to data published in Arthritis & Rheumatology.
“Glucocorticoids are a cornerstone in lupus nephritis therapy, and it is known that in combination with immunosuppression they can improve kidney outcomes, but can also increase the risk for infections,” Gabriel Figueroa-Parra, MD, an assistant professor of rheumatology at the Autonomous University of Nuevo León, in Mexico, told Healio. “There